2 news items
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AGIO
14 May 24
: risks and uncertainties related to the impact of pandemics or other public health emergencies to Agios' business, operations, strategy, goals
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AGIO
2 May 24
to a number of other important factors, including, without limitation: risks and uncertainties related to the impact of pandemics or other public health
- Prev
- 1
- Next